Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business
We haven't written up this one. Nikkei Asia has the full story — the link below goes straight to it.
More in World
Russia’s Air War Aims to Bleed Ukraine Dry
Vladimir Putin’s latest plan for victory puts a cease-fire well out of reach.
Arab national security indivisible, Houthi militia must be uprooted: academic
Dr. Ali Al-Anzi of King Saud University says eliminating the Houthi militia is essential to safeguard regional security and stability.
Test for Congress comeback in Nagaon Lok Sabha bypoll
The grand old party regained the key constituency from the BJP in 2019, but its two-time winner quit and became a BJP legislator in 2026
Matiang’i: Why opposition coalition talks won’t be easy
Jubilee Party boss acknowledges difficulty of forming coalition involving several presidential...
